Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Harpoon Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 46 | −2 |
| Shares | 18.9M | 93.0K | 17.4M | −1.38M (−7.3%) |
| Value | $13.7M | $67.0K | $12.9M | −$700.0K (−5.1%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lion Point Capital, LP | 169,283 | $126.0K | 0.07% |
| Bailard, Inc. | 63,200 | $47.0K | 0.00% |
| Two Sigma Investments, LP | 57,080 | $42.5K | 0.00% |
| Prudential Financial Inc | 43,400 | $32.3K | 0.00% |
| CM Wealth Advisors LLC | 50,354 | $29.0K | 0.01% |
| Zacks Investment Management | 30,042 | $22.4K | 0.00% |
| FMR LLC | 30 | $22 | 0.00% |
| Royal Bank of Canada | 600 | $0 | 0.00% |
| Hantz Financial Services, Inc. | 22 | $0 | 0.00% |
| IFP Advisors, Inc | 29 | – | – |
Sold out (12)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Levin Capital Strategies, L.P. | 330,000 | $239.5K |
| Goldman Sachs Group Inc | 111,601 | $81.0K |
| Two Sigma Securities, LLC | 30,702 | $22.3K |
| Citadel Advisors LLC | 14,457 | $10.5K |
| Virtu Financial LLC | 11,841 | $9.00K |
| Commonwealth Equity Services, LLC | 10,000 | $7.00K |
| Belpointe Asset Management LLC | 1,900 | $1.38K |
| FNY Investment Advisers, LLC | 2,000 | $1.00K |
| The PNC Financial Services Group, Inc. | 332 | $241 |
| GWM Advisors LLC | 115 | $83 |
| Citigroup Inc | 38 | $28 |
| Cutler Group LP | 600 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 93,000 | $67.0K |